Published on
Anticoagulation Therapy in Nonvalvular Atrial Fibrillation (NVAF): A Quality Improvement Initiative
Table of Contents
ACTIVITY DESCRIPTION/STATEMENT OF NEED
To address healthcare/practice gaps in care, the University of Florida, the Heart Rhythm Society, and PeerView Institute for Medical Education conducted a quality improvement initiative aimed at addressing barriers to DOAC use at the practice, provider, and patient levels. This 30-minute educational opportunity shares how the quality improvement initiative came together and what happened during and after the project. By the end, learners will be able to better recognize the burdens of untreated nonvalvular AF, understand the barriers to optimal use of anticoagulants, and learn strategies to overcome these barriers by implementing their own quality improvement initiatives.
TARGET AUDIENCE
This activity has been designed to meet the educational needs of family medicine physicians, general internal medicine physicians, cardiologists, advanced practice clinicians, nurses, pharmacists, and other clinicians involved in the care of patients with atrial fibrillation.
LEARNING OBJECTIVES
Upon completion of this activity, participants will be able to:
- Recognize the burden and consequences of untreated NVAF
- Assess barriers to suboptimal use of anticoagulants among prescribers and patients with NVAF
- Employ guidelines, new data, tools, and quality improvement strategies to overcome barriers to the evidence-based and guideline-directed use of DOACs in patients with NVAF
ACCREDITATION
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Successful completion of this nursing continuing professional development activity will be awarded 0.5 contact hour(s) and 0.12 contact hour(s) in the area of pharmacology.
Medical Learning Institute, Inc. designates this continuing education activity for 0.5 contact hours (0.05 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-0000-24-055-H01-P
Type of Activity: Knowledge
SUPPORT
This activity is supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance.
RELEASE AND EXPIRATION DATES:
June 13, 2024 – June 12, 2025
FACULTY DISCLOSURES AND COI
In accordance with ACCME requirements, the University of Florida College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/. No one else in a position to control content has any financial relationships to disclose. All relevant financial relationships have been mitigated.
Chair
Kun “Kevin” Xiang, MD, PhD
Assistant Professor of Medicine
Associate Program Director
Clinical Cardiac Electrophysiology Fellowship Program
Division of Cardiovascular Medicine
University of Florida Health
Gainesville, Florida
Kun “Kevin” Xiang, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AtriCure, Inc.
Medical Director
Margery Tamas, MPH
Margery Tamas, MPH, has no financial interests/relationships or affiliations in relation to this activity.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and PVI, PeerView Institute for Medical Education, our educational partner, do not have any relevant financial relationship(s) to disclose with ineligible companies unless listed below.
Generic Disclosure Statement
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.
INSTRUCTIONS FOR ACTIVITY COMPLETION
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 80% or higher is needed to obtain CME/MOC credit and 70% or higher to obtain NCPD/CPE credit. There are no prerequisites and there is no fee to participate in this activity or to receive CME/MOC/NCPD/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
For nurses, the post-test and evaluation are required in their entirety and a score of 70% or higher is needed to obtain Nursing Continuing Professional Development (NCPD) contact hours.
For pharmacists, upon receipt of the completed activity evaluation, you will receive an email from [email protected] within 2 weeks. MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
Media: Enduring Material
Release and Expiration Dates: June 13, 2024 – June 12, 2025
Time to Complete: 30 minutes
